Hereditary Cancer in Clinical Practice
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q3 | 46.5% | 1.049 | Q2 | 85.1% |
| 2024 | 2.4 | Q3 | 39.0% | 0.648 | Q3 | 71.0% |
| 2023 | 2.0 | Q3 | 31.7% | 0.729 | Q2 | 76.8% |
| 2022 | 1.7 | Q4 | 17.6% | 0.526 | Q3 | 67.7% |
| 2021 | 2.2 | Q4 | 32.8% | 0.546 | Q3 | 69.8% |
| 2020 | — | — | 0.857 | Q3 | 81.6% | |
| 2019 | — | — | 0.839 | Q2 | 81.5% | |
| 2018 | — | — | 0.843 | Q2 | 80.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1731-2302
ISSN
1897-4287
region
Western Europe
coverage
2003-2026